SDS Stock Overview
SDS Optic Spolka Akcyjna discovers, develops, produces, and commercializes diagnostics and monitoring tools worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
SDS Optic Spolka Akcyjna Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | zł25.25 |
| 52 Week High | zł41.00 |
| 52 Week Low | zł25.00 |
| Beta | 0 |
| 1 Month Change | -9.17% |
| 3 Month Change | -18.28% |
| 1 Year Change | -31.76% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 131.65% |
Recent News & Updates
Recent updates
Shareholder Returns
| SDS | PL Medical Equipment | PL Market | |
|---|---|---|---|
| 7D | -2.9% | -0.6% | 1.1% |
| 1Y | -31.8% | -12.7% | 27.5% |
Return vs Industry: SDS underperformed the Polish Medical Equipment industry which returned -11.4% over the past year.
Return vs Market: SDS underperformed the Polish Market which returned 25.7% over the past year.
Price Volatility
| SDS volatility | |
|---|---|
| SDS Average Weekly Movement | 4.4% |
| Medical Equipment Industry Average Movement | 4.5% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in PL Market | 9.6% |
| 10% least volatile stocks in PL Market | 3.2% |
Stable Share Price: SDS's share price has been volatile over the past 3 months.
Volatility Over Time: SDS's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2013 | n/a | n/a | www.sdsoptic.pl |
SDS Optic Spolka Akcyjna discovers, develops, produces, and commercializes diagnostics and monitoring tools worldwide. It offers inPROBE, a cancer diagnostics and treatment device that measure the level of active ingredients in cancer tumor cells. The company is also involved in the modeling and designing of package components, such as ferrules, housings, and other devices with flat and conical surface areas.
SDS Optic Spolka Akcyjna Fundamentals Summary
| SDS fundamental statistics | |
|---|---|
| Market cap | zł148.41m |
| Earnings (TTM) | zł0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs SDS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SDS income statement (TTM) | |
|---|---|
| Revenue | zł0 |
| Cost of Revenue | zł0 |
| Gross Profit | zł0 |
| Other Expenses | zł0 |
| Earnings | zł0 |
Last Reported Earnings
n/a
Next Earnings Date
May 15, 2024
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did SDS perform over the long term?
See historical performance and comparison